mTORC inhibitors as broad-spectrum therapeutics for age-related diseases
Chronological age represents the greatest risk factor for many life-threatening diseases, including neurodegeneration, cancer, and cardiovascular disease; ageing also increases susceptibility to infectious disease. Current efforts to tackle individual diseases may have little impact on the overall h...
Main Authors: | Walters, H, Cox, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2018
|
Similar Items
-
The localization of mTORC1 signaling
by: Peterson, Timothy Richard, Ph.D. Massachusetts Institute of Technology
Published: (2010) -
Amino acids and mTORC1: from lysosomes to disease
by: Efeyan, Alejo, et al.
Published: (2017) -
Amino acid regulation of mTORC1
by: Bar-Peled, Liron
Published: (2014) -
Lysosomal nutrients and the mTORC1 pathway
by: Wyant, Gregory A.(Gregory Andrew)
Published: (2019) -
Rapamycin inhibits mTORC1, but not completely
by: Thoreen, Carson C, et al.
Published: (2012)